Table-I.
Demographic and clinical characteristics of bacteremic and non-bacteremic groups.
| Bacteremic group n=64 | Non-bacteremic group n=92 | P-value | |
|---|---|---|---|
| Male (n, %) | 41(26.3) | 58(37.2) | |
| Female (n, %) | 23(14.7) | 34(21.8) | |
| Age (years, mean±SD) | 59.8±17.6 | 61±16.1 | 0.837 |
| Smoking (n,%) | 14(36.8) | 24(63.2) | 0.547 |
| Alcohol use (n,%) | 3(37.5) | 5(62.5) | 1.000 |
| History of antibiotic use (n, %) | 26(16.7) | 32(20.6) | |
| Length of stay (days, mean±SD) | 39.8±54.7 | 17.5±34.6 | 0.015 |
| Diagnoses (n,%) | |||
| SIRS | - | 17(18.5) | |
| Sepsis | 35(54.7) | 34(37.0) | 0.028 |
| Severe sepsis / Septicshock | 29(45.3) | 41(44.6) | 0.926 |
| Comorbidity (n,%) | |||
| Diabetes mellitus | 19(29.7) | 24(26.1) | 0.621 |
| Chronic heart failure | 6(9.4) | 12(13.0) | 0.481 |
| Hypertension | 20(31.3) | 33(35.9) | 0.549 |
| Chronic renal disease | 10(15.6) | 11(12.0) | 0.549 |
| Solid organ malignancy | 5(7.8) | 8(8.7) | 0.844 |
| Chronic lung disease | 5(7.8) | 22(23.9) | 0.009 |
| Cardiac arrhythmia | 2(3.1) | 11(12.0) | 0.049 |
| Coronary heart disease | 8(12.5) | 17(18.5) | 0.317 |
| Cerebrovascular disease | 8(12.5) | 8(8.7) | 0.441 |
| Management (n,%) | |||
| Medical patients | 37(57.8) | 51(55.4) | 0.768 |
| Surgical patients | 27(42.2) | 41(44.6) | |
| Mechanical ventilation | 48(75.0) | 76(82.6) | 0.247 |
| Vasopressor use | 29(45.3) | 41(44.6) | 0.926 |
| Laboratory findings (n, mean±SD) | |||
| White blood cell count (K/uL) | 13169.4±7427.0 | 15404.8±9105.5 | 0.133 |
| Hemoglobin (g/dL) | 10.0±1.7 | 10.4±2.1 | 0.157 |
| Eosinophil (K/uL) | 118.1±201.9 | 72.9±110.6 | 0,181 |
| Platelet (K/uL) | 206578.1±135123.6 | 241608.7±143198,3 | 0.141 |
| Sedimentation (mm) | 59.9±31.1 | 57.1±33.5 | 0.551 |
| CRP (mg/dl) | 18.6±8.9 | 17.5±10.1 | 0.343 |
| PCT (ng/dl) | 11.9±21.5 | 5.9±11.5 | 0.168 |
| NLCR | 14.9±15.2 | 16.6±15.0 | 0.337 |
| Neopterin (nmol/L) | 20.9±36.2 | 12.1±13.9 | 0.167 |
| Pro-ADM (ng/L) | 632.0±721.0 | 438.2±393.1 | 0.172 |
| Mortality (n,%) | |||
| Overall mortality | 41(43.6) | 53(56.4) | 0.418 |
| 28-day mortality | 29(36.7) | 50(63.3) | 0.002 |
| APACHEII score(mean±SD) | 24.5±8.9 | 24.5±8.9 | 0.891 |
| SOFA score(mean±SD) | 9.4±4.1 | 9.1±4.3 | 0.804 |
| Charlson comorbidity index(mean±SD) | 5.4±3.5 | 5.4±3.6 | 0.830 |
*SD: Standart Deviation,
SIRS: Systemic inflammatory response syndrome,
CRP: C-reactive protein.